V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10005307 | 10003313 | 1.66 | 100 | Palliative (P) | 2017-11-29 | 2018-05-23 | MPT | N | N | 10418794 | CYTARABINE |
| 10005308 | 10003314 | 1.8 | null | Disease modification (D) | 2015-03-11 | 2015-03-31 | RUXOLITINIB | N | null | 10419975 | MYELOMA XI TRIAL |
| 10005309 | 10003314 | 1.61 | 66 | Disease modification (D) | 2019-01-11 | 2019-01-11 | MPV (cycle 1-4) | null | null | 10419975 | MITOMYCIN |
| 10005310 | 10003315 | 1.68 | 0 | Palliative (P) | null | 2018-12-03 | Cytarabine Low Dose | 02 | N | 10420400 | MPT |
| 10005311 | 10006841 | null | 57.7 | Curative (C) | 2019-06-20 | 2019-06-25 | VINORELBINE | null | N | 10420440 | AFLIBERCEPT + FU + IRINOTECAN |
| 10005312 | 10003316 | 1.8 | 87.4 | Palliative (P) | null | 2019-06-28 | Capecitabine + Mitomycin | N | null | 10420608 | CISPLATIN + FLUOROURACIL |
| 10005313 | 10003317 | 1.53 | 53.6 | Curative (C) | 2018-10-13 | 2018-10-17 | CHLVPP | N | N | 10420706 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 10005314 | 10006842 | 1.67 | 0 | Disease modification (D) | null | 2017-08-06 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 10420932 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 10005315 | 10008278 | 0 | 0 | Disease modification (D) | null | 2018-10-26 | CYCLOPHOSPHAMIDE + RITUXIMAB + Dexamethasone | N | N | 10421057 | BENDAMUSTINE + THALIDOMIDE |
| 10005316 | 10008875 | 1.74 | 72.3 | Disease modification (D) | 2018-09-19 | 2018-10-09 | CISPLATIN + FLUOROURACIL | 02 | N | 10421463 | SORAFENIB |
| 10005317 | 10003318 | 1.57 | 57.3 | Palliative (P) | 2016-07-22 | 2016-08-01 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINBLASTINE | N | N | 10421623 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 10005318 | 10003319 | null | 63.6 | Palliative (P) | 2018-01-13 | 2018-02-02 | CARBOPLATIN + RT | 02 | N | 10421696 | BORTEZOMIB + THALIDOMIDE |
| 10005319 | 10003319 | null | 75.45 | Palliative (P) | 2016-03-12 | 2016-03-12 | GEMCITABINE + NAB PACLITAXEL | 02 | N | 10421696 | ERLOTINIB |
| 10005320 | 10008279 | 1.55 | null | Palliative (P) | 2018-10-28 | 2018-11-10 | CMF IV (28 day) | 2 | null | 10421806 | CYCLOPHOSPHAMIDE |
| 10005321 | 10008279 | 1.72 | 61 | Disease modification (D) | 2018-08-28 | 2018-08-29 | AML16 Azacitidine | N | N | 10421806 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 10005322 | 10003320 | null | 72.8 | Palliative (P) | 2018-06-09 | 2018-07-05 | Bendamustine +/- Prednisolone | N | Y | 10421917 | STAMPEDE TRIAL |
| 10005323 | 10003321 | 1.73 | 0 | Palliative (P) | 2018-08-04 | 2018-09-03 | Vemurafenib | N | N | 10422106 | CAPECITABINE + CARBOPLATIN |
| 10005324 | 10003321 | null | 0 | Curative (C) | 2017-08-27 | 2017-09-17 | CETUXIMAB + IRINOTECAN + MDG | 2 | Y | 10422106 | NOT MATCHED |
| 10005325 | 10003322 | 1.74 | 97.8 | Disease modification (D) | 2016-10-04 | 2016-10-04 | GEMCITABINE + NAB PACLITAXEL | 02 | N | 10422338 | CETUXIMAB |
| 10005326 | 10003323 | null | 63.5 | Palliative (P) | 2015-02-04 | 2015-02-07 | CHLVPP | 02 | N | 10422523 | LENALIDOMIDE |
| 10005327 | 10003323 | null | 61.8 | Palliative (P) | 2016-04-26 | 2016-04-26 | IBRUTINIB | N | N | 10422523 | CYCLOPHOSPHAMIDE + DOCETAXEL |
| 10005328 | 10003324 | 1.69 | 60 | Not known (9) | 2016-07-03 | 2016-07-26 | Capecitabine (21days) + Carboplatin | 02 | N | 10422820 | PAZOPANIB |
| 10005329 | 10003324 | 0 | 0 | Curative (C) | 2016-11-16 | 2016-11-16 | VINCRISTINE | 01 | N | 10422820 | PAZOPANIB |
| 10005330 | 10003325 | 1.77 | 110 | Palliative (P) | 2019-04-10 | 2019-04-15 | PERM Trial | 02 | N | 10422899 | CETUXIMAB + IRINOTECAN + MDG |
| 10005331 | 10003326 | 1.76 | 77.7 | Curative (C) | 2018-07-23 | 2018-08-11 | Sorafenib | N | N | 10423299 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 10005332 | 10003327 | 1.78 | 62.2 | Palliative (P) | 2017-03-29 | 2017-04-09 | Pemetrexed | N | N | 10423733 | CHLVPP |
| 10005333 | 10003328 | 1.72 | null | Palliative (P) | 2017-06-01 | 2017-06-08 | CETUXIMAB + RT | N | N | 10424273 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 10005334 | 10003329 | 1.48 | 74 | Curative (C) | 2018-01-03 | 2018-01-13 | Bevacizumab | N | N | 10424306 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN |
| 10005335 | 10003330 | 1.6 | 75.4 | Curative (C) | 2018-12-27 | 2018-12-28 | Dacarbazine | N | N | 10424549 | IRINOTECAN |
| 10005336 | 10003330 | null | null | Palliative (P) | 2014-12-24 | 2014-12-24 | Trastuzumab Subcutaneous | N | N | 10424549 | TEMOZOLOMIDE |
| 10005337 | 10003331 | 1.78 | 55.6 | Adjuvant (A) | 2018-08-09 | 2018-08-10 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | N | 10424603 | BORTEZOMIB + THALIDOMIDE |
| 10005338 | 10003332 | null | null | Palliative (P) | 2017-10-07 | 2017-11-05 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 10424711 | CHLORAMBUCIL + OBINUTUZUMAB |
| 10005339 | 10003332 | 1.7 | 40.2 | null | 2019-03-11 | 2019-03-18 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | N | N | 10424711 | ERLOTINIB |
| 10005340 | 10003332 | 1.58 | 51 | null | 2017-07-30 | 2017-08-09 | RUXOLITINIB | N | N | 10424711 | CISPLATIN + FLUOROURACIL |
| 10005341 | 10003332 | null | 83.9 | Curative (C) | 2016-07-15 | 2016-07-17 | BORTEZOMIB + THALIDOMIDE | null | N | 10424711 | CETUXIMAB |
| 10005342 | 10003332 | 1.68 | 100.7 | Curative (C) | 2015-09-10 | 2015-09-11 | CRIZOTINIB | N | N | 10424711 | IPILIMUMAB + NIVOLUMAB |
| 10005343 | 10003332 | 1.65 | 101.5 | null | 2018-12-14 | 2018-12-14 | RCEOP | N | N | 10424711 | CETUXIMAB |
| 10005344 | 10003333 | 1.62 | 63.6 | null | 2017-08-05 | 2017-09-03 | IDELALISIB | 2 | N | 10425608 | VINCRISTINE |
| 10005345 | 10003334 | 1.71 | 92.4 | Palliative (P) | 2018-12-20 | 2018-12-21 | Bendamustine +/- Prednisolone | 02 | N | 10425761 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 10005346 | 10003335 | 1.61 | 58.8 | null | 2016-12-07 | 2016-12-09 | Cyclophos + Dex + Lenalidomide | 02 | N | 10425847 | PAZOPANIB |
| 10005347 | 10003336 | null | 82.4 | Disease modification (D) | 2016-04-07 | 2016-04-23 | R CODOX M | N | N | 10426222 | BENDAMUSTINE |
| 10005348 | 10003337 | null | 75.8 | Palliative (P) | 2015-12-20 | 2015-12-20 | Cisplatin + Fluorouracil + RT 5day | 02 | N | 10426315 | OCTREOTIDE |
| 10005349 | 10003338 | null | null | null | 2018-08-24 | 2018-08-24 | Bendamustine +/- Prednisolone | N | null | 10426395 | CHLVPP |
| 10005350 | 10003339 | 0 | null | Palliative (P) | 2018-04-24 | 2018-05-14 | IBRUTINIB | N | Y | 10426600 | ERLOTINIB |
| 10005351 | 10003340 | null | 87 | Adjuvant (A) | 2018-02-23 | 2018-03-01 | IRINOTECAN + MDG + PANITUMUMAB | N | N | 10427310 | BORTEZOMIB + THALIDOMIDE |
| 10005352 | 10003340 | null | 85 | Palliative (P) | 2018-08-18 | 2018-09-05 | Panitumumab | N | Y | 10427310 | CHLORAMBUCIL + OBINUTUZUMAB |
| 10005353 | 10003340 | null | 72.7 | Curative (C) | 2017-11-29 | 2017-12-01 | DABRAFENIB + TRAMETINIB | N | N | 10427310 | MPT |
| 10005354 | 10003340 | 1.57 | null | Curative (C) | 2019-04-26 | 2019-04-30 | Trastuzumab 21 day loading dose | N | N | 10427310 | AFATINIB |
| 10005355 | 10003341 | 1.8 | 0 | Palliative (P) | 2017-12-17 | 2017-12-19 | Bexarotene | N | N | 10430455 | CISPLATIN + FLUOROURACIL |
| 10005356 | 10003342 | null | null | Adjuvant (A) | 2017-12-07 | 2017-12-17 | Cyclophosphamide + Docetaxel | N | N | 10430552 | DOCETAXEL + TRASTUZUMAB |